Breaking News

AGC Biologics Introduces AGCellerate to Deliver IND-Ready GMP Material

Program launches with fixed price and 1.0KG of product in 11 months for monoclonal antibody project.

AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), launched AGCellerate, a new program designed to deliver effective IND-ready GMP material for biopharmaceutical developers. AGCellerate offers guaranteed amounts at fixed timelines and costs and is designed to help accelerate projects through development and into clinical phases.  The new program offers support to biologics projects using monoclonal antibodies (mAbs), lentiviral vectors, adeno...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters